sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
6-Jul-2015 18:20
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 576-600 out of 1068.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>

Public Release: 25-Aug-2014
Proceedings of the National Academy of Sciences
MU researchers discover protein's ability to inhibit HIV release
A family of proteins that promotes virus entry into cells also has the ability to block the release of HIV and other viruses, University of Missouri researchers have found.

Contact: Derek Thompson
University of Missouri-Columbia

Public Release: 25-Aug-2014
Illinois scientists work with World Health Organization to fortify condiments, seasonings
Two University of Illinois scientists are contributing to World Health Organization efforts to fortify condiments and seasonings for use in countries with widespread micronutrient deficiencies.
World Health Organization

Contact: Phyllis Picklesimer
University of Illinois College of Agricultural, Consumer and Environmental Sciences

Public Release: 25-Aug-2014
Proceedings of the National Academy of Sciences
Black carbon -- a major climate pollutant -- also linked to cardiovascular health
Black carbon pollutants from wood smoke are known to trap heat near the earth's surface and warm the climate. A new study led by McGill professor Jill Baumgartner suggests that black carbon may also increase women's risk of cardiovascular disease.

Contact: Cynthia Lee
McGill University

Public Release: 25-Aug-2014
Aging Cell
APOB, a gene involved in lipid transport, linked to cases of familial extreme longevity
In a recent report in Aging Cell, a multidisciplinary team of Spanish scientists, led by Tim Cash and Manuel Serrano at the Spanish National Cancer Research Centre, identify rare variants in the APOB gene in several families where exceptional longevity (>100 years of age) appears to cluster.

Contact: Nuria Noriega
Centro Nacional de Investigaciones Oncologicas (CNIO)

Public Release: 22-Aug-2014
Molecular Nutrition and Food Research
Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's
The onset of Alzheimer's disease can be slowed and some of its symptoms curbed by a natural compound that is found in pomegranate. Also, the painful inflammation that accompanies illnesses such as rheumatoid arthritis and Parkinson's disease could be reduced, according to the findings of a two-year project headed by University of Huddersfield scientist Dr. Olumayokun Olajide, who specialises in the anti-inflammatory properties of natural products.

Contact: Nicola Werritt
University of Huddersfield

Public Release: 21-Aug-2014
Poll finds many in US lack knowledge about Ebola and its transmission
Although the Centers for Disease and Prevention reports no known cases of Ebola transmission in the US, a Harvard School of Public Health/SSRS poll released today shows that four in 10 adults in the US are concerned that there will be a large outbreak in the US, and one-quarter are concerned that they or someone in their immediate family may get sick with Ebola over the next year.

Contact: Marge Dwyer
Harvard School of Public Health

Public Release: 21-Aug-2014
CHEST releases new expert guidance in care of the critically ill and injured
The American College of Chest Physicians (CHEST) announces the immediate release of Care of the Critically Ill and Injured During Pandemics and Disasters: CHEST Consensus Statement today in the Online First section of the journal CHEST while the global health-care community cares for patients with the Ebola virus.
US Centers for Disease Control and Prevention

Contact: Kristi Bruno
American College of Chest Physicians

Public Release: 21-Aug-2014
A novel 'man and machine' decision support system makes malaria diagnostics more effective
A Finnish-Swedish research group has developed a novel 'man and machine' decision support system for diagnosing malaria infection. The method is based on computer vision algorithms combined with visualization of the relevant sample areas to human observers on a tablet computer. The system has a huge potential to increase the throughput in malaria diagnostics. Several other medical applications are in the development stage.

Contact: Dr. Nina Linder
University of Helsinki

Public Release: 20-Aug-2014
New England Journal of Medicine
NEJM Perspective: 'Studying 'Secret Serums' -- Toward Safe, Effective Ebola Treatments'
Conducting clinical studies of agents to treat Ebola and allowing compassionate use of those agents are not necessarily mutually exclusive, writes Georgetown University Medical Center's Jesse L. Goodman, M.D., M.P.H., in a perspective piece published Wednesday in the New England Journal of Medicine.

Contact: Karen Tever
Georgetown University Medical Center

Public Release: 20-Aug-2014
New research shows seals and sea lions likely spread tuberculosis to humans
Scientists who study tuberculosis have long debated its origins. New research shows that tuberculosis likely spread from humans in Africa to seals and sea lions that brought the disease to South America and transmitted it to Native people there before Europeans landed on the continent.
National Science Foundation, European Research Council, Smithsonian Institution, Swiss National Science Foundation, National Institutes of Health, Wenner-Gren Foundation, Wellcome Trust

Contact: Julie Newberg
Arizona State University

Public Release: 19-Aug-2014
Infection and Immunity
New vaccine shows promise as stronger weapon against both tuberculosis and leprosy
A new University of California Los Angeles-led study finds that a recombinant variant of the century-old vaccine Bacille Calmette-Guerin is superior to Bacille Calmette-Guerin in protecting against tuberculosis in animal models, and also cross protects against leprosy. In addition, the researchers found that boosting that variant, called rBCG30, with a particular protein found in both tuberculosis and leprosy provides considerably stronger protection against leprosy.
National Institutes of Health, National Hansen's Disease Programs, University of California Los Angeles Jonsson Comprehensive Cancer Center, Center for AIDS Research

Contact: Enrique Rivero
University of California - Los Angeles Health Sciences

Public Release: 19-Aug-2014
Water Resources Research
This week from AGU: Long-term ecological research, predicting cholera outbreaks
This week from the American Geophysical Union: Long-term ecological research, predicting cholera outbreaks

Contact: Alexandra Branscombe
American Geophysical Union

Public Release: 19-Aug-2014
Biophysical Journal
Laser optical tweezers reveal how malaria parasites infect red blood cells
Little is known about how malaria invades one red blood cell after another because it happens so quickly. In a new study, researchers used laser optical tweezers to study interactions between the disease-causing parasite and red blood cells. The findings reveal surprising new insights into malaria biology and pave the way for the development of more effective drugs or vaccines for a disease that affects hundreds of millions of people around the world.

Contact: Mary Beth O'Leary
Cell Press

Public Release: 18-Aug-2014
Clinical Microbiology and Infection
Invasion of the Americas by mosquito-borne virus likely
While media attention has been focused recently on coronavirus cases in the Arabian peninsula and the Ebola outbreak in West Africa, experts note that another threat lies in the spread of Chikungunya fever, an illness that is transmitted by mosquitoes and can cause fever, joint and muscle pain, headaches, and rashes. While it does not often cause death, the symptoms can be severe and disabling, with no treatment available.

Contact: Nicole Weingartner

Public Release: 18-Aug-2014
Journal of Animal Ecology
Ebola has profound effects on wildlife population dynamics
New research in gorillas that were affected by an Ebola virus outbreak shows that disease can influence reproductive potential, immigration and social dynamics, and it highlights the need to develop complex models that integrate all the different impacts of a disease.

Contact: Nicole Weingartner

Public Release: 18-Aug-2014
Annals of Internal Medicine
Doctors worldwide should stay current on developments in ongoing Ebola epidemic
Doctors in hospitals and emergency rooms around the world should be prepared to recognize Ebola virus infection and isolate patients if necessary, infectious disease specialists recommend. However, concerns that Ebola will spread beyond West Africa to Europe and North America are unfounded because of the way Ebola is transmitted and because of highly developed hospital infection control practices.

Contact: Holly Korschun
Emory Health Sciences

Public Release: 15-Aug-2014
UTMB named a World Health Organization Collaborating Center for Vaccine Research
The world experts on vaccine development at the University of Texas Medical Branch at Galveston have received an international designation acknowledging their unique niche in a sphere where research, government regulation and big pharma often collide.

Contact: Molly Dannenmaier
University of Texas Medical Branch at Galveston

Public Release: 14-Aug-2014
Annals of Global Health
Global public health objectives need to address substance abuse in developing countries
Substance addiction is a large and growing problem for developing societies. A new study that surveyed reports on modalities for treating addiction and their effectiveness in the developing world calls on policymakers to use this information to support the design of programs that meet known population needs. The study also encourages looking at ways to adapt the Alcoholics Anonymous model to fit different cultural norms. The findings are published in the Annals of Global Health.

Contact: Eileen Leahy
Elsevier Health Sciences

Public Release: 14-Aug-2014
JAIDS: Journal of Acquired Immune Deficiency Syndromes
Scientists detail urgent research agenda to address chronic disease toll
According to recommendations resulting from a multidisciplinary conference sponsored by the National Institutes of Health, scientists and physicians in low- and middle-income countries should build on existing HIV research to study and treat chronic conditions.

Contact: Jeff Gray
NIH/Fogarty International Center

Public Release: 13-Aug-2014
New England Journal of Medicine
Ebola outbreak highlights global disparities in health-care resources
The outbreak of Ebola virus disease that has claimed more than 1,000 lives in West Africa this year poses a serious, ongoing threat to that region: the spread to capital cities and Nigeria -- Africa's most populous nation -- presents new challenges for healthcare professionals. The situation has garnered significant attention and fear around the world, but proven public health measures and sharpened clinical vigilance will contain the epidemic and thwart a global spread.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 13-Aug-2014
Cell Host & Microbe
New insights into the survival and transmission strategy of malaria parasites
Malaria parasites exploit the function of the epigenetic regulator HP1 to promote survival and transmission between human hosts, a new study shows. Using HP1 the parasite controls expression of surface antigens to escape immune responses in the infected victim. This prolongs survival of the parasite in the human blood stream and secures its transmission via mosquitoes. The study paves important avenues for new intervention strategies to prevent severe disease and malaria transmission.
Swiss National Science Foundation, Singaporean National Medical Research Council, OPO Foundation, Rudolf Geigy Foundation, Boehringer Ingelheim Fonds

Contact: Christian Heuss
Swiss Tropical and Public Health Institute

Public Release: 13-Aug-2014
JAIDS: Journal of Acquired Immune Deficiency Syndromes
With advances in HIV care, survivors face other disease risks
As effective treatments for HIV become more widely available in low-income and middle-income countries, there's an urgent need to assess and manage health risks in the growing number of people living with HIV. An update on non-communicable diseases among HIV-positive populations in low-income and middle-income countries appears as a supplement to in JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Contact: Connie Hughes
Wolters Kluwer Health

Public Release: 13-Aug-2014
Cell Host & Microbe
Ebola protein blocks early step in body's counterattack on virus
The newly published study explains for the first time how the production by the virus of a protein called Ebola Viral Protein 24 stops the interferon-based signals from ramping up immune defenses.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Greg Williams
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 13-Aug-2014
Emerging Microbes & Infections
Researchers uncover clues about how the most important TB drug attacks its target
Researchers at the Johns Hopkins Bloomberg School of Public Health say they have discovered a new clue to understanding how the most important medication for tuberculosis (TB) works to attack dormant TB bacteria in order to shorten treatment.
NIH/National Institute of Allergy and Infectious Diseases, Major Project of the Twelfth Five-Year Plan, National Natural Science Foundation of China

Contact: Stephanie Desmon
Johns Hopkins University Bloomberg School of Public Health

Public Release: 13-Aug-2014
Cell Host & Microbe
Researchers uncover how Ebola virus disables immune response
The Ebola outbreak in West Africa has brought a lot of attention to the deadly virus. According to the World Health Organization, up to 90 percent of those infected with Ebola die from the virus. Now, researchers publishing Aug. 13 in the journal Cell Host & Microbe reveal how Ebola blocks and disables the body's natural immune response. Understanding how Ebola disarms immune defenses will be crucial in the development of new treatments for the disease.

Contact: Mary Beth O'Leary
Cell Press

Showing releases 576-600 out of 1068.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>